logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9670166 B1

PDFFull Text
Date of Patent:
Jun. 06, 2017

Filed:

Aug. 05, 2016

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Applicant:

Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;

Inventors:

Christian Gnamm, Biberach an der Riss, DE;

Thorsten Oost, Biberach an der Riss, DE;

Stefan Peters, Biberach an der Riss, DE;

Holger Hoesch, Biberach an der Riss, DE;

Uwe Joerg Ries, Biberach an der Riss, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:

Michael P. Morris

Philip I. Datlow

Primary Examiner:

Venkataraman Balasubramanian

Int. Cl.
CPC ...
C07D 239/70 (2006.01); C07D 403/12 (2006.01); C07D 401/12 (2006.01); A61K 31/517 (2006.01); A61P 9/12 (2006.01); C07D 487/04 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 401/04 (2006.01); C07D 405/06 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 239/70 (2013.01); A61K 31/517 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract

This invention relates to substituted bicyclic dihydropyrimidinones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other autoimmune and allergic disorders, allograft rejection, and oncological diseases.

Find Patent Forward Citations

Loading…